These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21721554)

  • 1. Fluorescence probe for lysophospholipase C/NPP6 activity and a potent NPP6 inhibitor.
    Kawaguchi M; Okabe T; Okudaira S; Hanaoka K; Fujikawa Y; Terai T; Komatsu T; Kojima H; Aoki J; Nagano T
    J Am Chem Soc; 2011 Aug; 133(31):12021-30. PubMed ID: 21721554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and molecular characterization of a novel choline-specific glycerophosphodiester phosphodiesterase belonging to the nucleotide pyrophosphatase/phosphodiesterase family.
    Sakagami H; Aoki J; Natori Y; Nishikawa K; Kakehi Y; Natori Y; Arai H
    J Biol Chem; 2005 Jun; 280(24):23084-93. PubMed ID: 15788404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-Glycomic and Microscopic Subcellular Localization Analyses of NPP1, 2 and 6 Strongly Indicate that trans-Golgi Compartments Participate in the Golgi to Plastid Traffic of Nucleotide Pyrophosphatase/Phosphodiesterases in Rice.
    Kaneko K; Takamatsu T; Inomata T; Oikawa K; Itoh K; Hirose K; Amano M; Nishimura S; Toyooka K; Matsuoka K; Pozueta-Romero J; Mitsui T
    Plant Cell Physiol; 2016 Aug; 57(8):1610-28. PubMed ID: 27335351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and X-ray crystal structure-based optimization of autotaxin (ENPP2) inhibitors, using a newly developed fluorescence probe.
    Kawaguchi M; Okabe T; Okudaira S; Nishimasu H; Ishitani R; Kojima H; Nureki O; Aoki J; Nagano T
    ACS Chem Biol; 2013 Aug; 8(8):1713-21. PubMed ID: 23688339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleotide pyrophosphatase/phosphodiesterase 1 exerts a negative effect on starch accumulation and growth in rice seedlings under high temperature and CO2 concentration conditions.
    Kaneko K; Inomata T; Masui T; Koshu T; Umezawa Y; Itoh K; Pozueta-Romero J; Mitsui T
    Plant Cell Physiol; 2014 Feb; 55(2):320-32. PubMed ID: 24092883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diadenosine 5',5''-(boranated)polyphosphonate analogues as selective nucleotide pyrophosphatase/phosphodiesterase inhibitors.
    Eliahu S; Lecka J; Reiser G; Haas M; Bigonnesse F; Lévesque SA; Pelletier J; Sévigny J; Fischer B
    J Med Chem; 2010 Dec; 53(24):8485-97. PubMed ID: 21090681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an activity-based probe for autotaxin.
    Cavalli S; Houben AJ; Albers HM; van Tilburg EW; de Ru A; Aoki J; van Veelen P; Moolenaar WH; Ovaa H
    Chembiochem; 2010 Nov; 11(16):2311-7. PubMed ID: 20941725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of the non-catalytic ectodomains of the nucleotide pyrophosphatase/phosphodiesterase NPP1.
    Gijsbers R; Ceulemans H; Bollen M
    Biochem J; 2003 Apr; 371(Pt 2):321-30. PubMed ID: 12533192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonhydrolyzable ATP analogues as selective inhibitors of human NPP1: a combined computational/experimental study.
    Lecka J; Ben-David G; Simhaev L; Eliahu S; Oscar J; Luyindula P; Pelletier J; Fischer B; Senderowitz H; Sévigny J
    J Med Chem; 2013 Nov; 56(21):8308-20. PubMed ID: 24083941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of sulfonate and sulfamate derivatives possessing benzofuran or benzothiophene nucleus as inhibitors of nucleotide pyrophosphatases/phosphodiesterases and anticancer agents.
    Anbar HS; El-Gamal R; Ullah S; Zaraei SO; Al-Rashida M; Zaib S; Pelletier J; Sévigny J; Iqbal J; El-Gamal MI
    Bioorg Chem; 2020 Nov; 104():104305. PubMed ID: 33017718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D.
    Jansen S; Stefan C; Creemers JW; Waelkens E; Van Eynde A; Stalmans W; Bollen M
    J Cell Sci; 2005 Jul; 118(Pt 14):3081-9. PubMed ID: 15985467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hits of a high-throughput screen identify the hydrophobic pocket of autotaxin/lysophospholipase D as an inhibitory surface.
    Fells JI; Lee SC; Fujiwara Y; Norman DD; Lim KG; Tsukahara R; Liu J; Patil R; Miller DD; Kirby RJ; Nelson S; Seibel W; Papoian R; Parrill AL; Baker DL; Bittman R; Tigyi G
    Mol Pharmacol; 2013 Sep; 84(3):415-24. PubMed ID: 23793291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NPP-type ectophosphodiesterases: unity in diversity.
    Stefan C; Jansen S; Bollen M
    Trends Biochem Sci; 2005 Oct; 30(10):542-50. PubMed ID: 16125936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of novel quinazoline-4-piperidinesulfamide derivatives as inhibitors of NPP1.
    Forcellini E; Boutin S; Lefebvre CA; Shayhidin EE; Boulanger MC; Rhéaume G; Barbeau X; Lagüe P; Mathieu P; Paquin JF
    Eur J Med Chem; 2018 Mar; 147():130-149. PubMed ID: 29427906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The discovery of potent, selective, and orally active pyrazoloquinolines as PDE10A inhibitors for the treatment of Schizophrenia.
    Ho GD; Yang SW; Smotryski J; Bercovici A; Nechuta T; Smith EM; McElroy W; Tan Z; Tulshian D; McKittrick B; Greenlee WJ; Hruza A; Xiao L; Rindgen D; Mullins D; Guzzi M; Zhang X; Bleickardt C; Hodgson R
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1019-22. PubMed ID: 22222034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate-specifying determinants of the nucleotide pyrophosphatases/phosphodiesterases NPP1 and NPP2.
    Cimpean A; Stefan C; Gijsbers R; Stalmans W; Bollen M
    Biochem J; 2004 Jul; 381(Pt 1):71-7. PubMed ID: 15096095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyoxometalates--potent and selective ecto-nucleotidase inhibitors.
    Lee SY; Fiene A; Li W; Hanck T; Brylev KA; Fedorov VE; Lecka J; Haider A; Pietzsch HJ; Zimmermann H; Sévigny J; Kortz U; Stephan H; Müller CE
    Biochem Pharmacol; 2015 Jan; 93(2):171-81. PubMed ID: 25449596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-directed mutations in the tumor-associated cytokine, autotaxin, eliminate nucleotide phosphodiesterase, lysophospholipase D, and motogenic activities.
    Koh E; Clair T; Woodhouse EC; Schiffmann E; Liotta L; Stracke M
    Cancer Res; 2003 May; 63(9):2042-5. PubMed ID: 12727817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly Selective and Potent Ectonucleotide Pyrophosphatase-1 (NPP1) Inhibitors Based on Uridine 5'-P
    Zelikman V; Pelletier J; Simhaev L; Sela A; Gendron FP; Arguin G; Senderowitz H; Sévigny J; Fischer B
    J Med Chem; 2018 May; 61(9):3939-3951. PubMed ID: 29681152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imidazopyridine- and purine-thioacetamide derivatives: potent inhibitors of nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1).
    Chang L; Lee SY; Leonczak P; Rozenski J; De Jonghe S; Hanck T; Müller CE; Herdewijn P
    J Med Chem; 2014 Dec; 57(23):10080-100. PubMed ID: 25372276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.